Publication | Closed Access

Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model

Neurodegenerative DiseasesAlzheimer's DiseaseAmyloid β1–42 LevelsNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationMedicineGeriatric Neurology